3 awesome stocks for a crappy bear market
Marc Kennis, June 10, 2022
In the current bear market, which stocks can you buy ?
In the current crappy bear market, stock valuations remain low as labour shortages and inflation bite, but there are still good stock opportunities. Stuart Roberts from Stocks Down Under says he can’t believe the valuations of some companies, telling us he sees great value in Perenti Global (ASX:PRN), a valuation of three times earnings being a steal, given it recently increased profit by 20%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Another pick of Stuart’s is Macmahon (ASX:MAH) after the company successfully completed the commissioning of its full processing circuit at the Warrawoona Gold Project in Western Australia.
Looking broader, Stuart likes the oil and gas industry, particularly the larger names. Stock specific, in Stuart’s eyes it is all about ASX-listed mega-caps, which to him are safer bets, like Woodside (ASX:WDS), with a larger workforce that isn’t as impacted by staff turnover post COVID-19 lockdowns.
Going abroad, Stuart said with increased sovereign risk post the Russian invasion of Ukraine and China flexing its muscles, he prefers Tier 1 economies, such as the United States, Japan and Germany in the current bear market.
Watch the full interview below!
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…